Russell NH - Search Results

1

Addition of the mammalian target of rapamycin inhibitor, everolimus, to consolidation therapy in acute myeloid leukemia: experience from the UK NCRI AML17 trial.

Burnett AK, Das Gupta E, Knapper S, Khwaja A, Sweeney M, Kjeldsen L, Hawkins T, Betteridge SE, Cahalin P, Clark RE, Hills RK, Russell NH; UK NCRI AML Study Group. Burnett AK, et al. Among authors: russell nh. Haematologica. 2018 Oct;103(10):1654-1661. doi: 10.3324/haematol.2018.189514. Epub 2018 Jul 5. Haematologica. 2018. PMID: 29976746 Free PMC article. Clinical Trial.

2

The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia.

Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das-Gupta E. Seedhouse C, et al. Blood. 2002 Nov 15;100(10):3761-6. doi: 10.1182/blood-2002-04-1152. Epub 2002 Jul 18. Blood. 2002. PMID: 12393447 Free article.

3

BAT-25 and BAT-26, two mononucleotide microsatellites, are not sensitive markers of microsatellite instability in acute myeloid leukaemia.

Faulkner RD, Seedhouse CH, Das-Gupta EP, Russell NH. Faulkner RD, et al. Among authors: russell nh. Br J Haematol. 2004 Jan;124(2):160-5. doi: 10.1046/j.1365-2141.2003.04750.x. Br J Haematol. 2004. PMID: 14687025 Free article.

4

Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia.

Seedhouse C, Faulkner R, Ashraf N, Das-Gupta E, Russell N. Seedhouse C, et al. Clin Cancer Res. 2004 Apr 15;10(8):2675-80. doi: 10.1158/1078-0432.ccr-03-0372. Clin Cancer Res. 2004. PMID: 15102670

5

The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors.

Shaw BE, Russell NH, Devereux S, Das-Gupta E, Mackinnon S, Madrigal JA, Pagliuca A, Mufti GJ, Byrne JL. Shaw BE, et al. Among authors: russell nh. Haematologica. 2005 Nov;90(11):1562-9. Haematologica. 2005. PMID: 16266905

6

Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia.

Tauro S, Craddock C, Peggs K, Begum G, Mahendra P, Cook G, Marsh J, Milligan D, Goldstone A, Hunter A, Khwaja A, Chopra R, Littlewood T, Peniket A, Parker A, Jackson G, Hale G, Cook M, Russell N, Mackinnon S. Tauro S, et al. J Clin Oncol. 2005 Dec 20;23(36):9387-93. doi: 10.1200/JCO.2005.02.0057. Epub 2005 Nov 28. J Clin Oncol. 2005. PMID: 16314618 Clinical Trial.

7

The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.

Cook G, Clark RE, Crawley C, Mackinnon S, Russell N, Thomson K, Pearce RM, Towlson K, Marks DI. Cook G, et al. Biol Blood Marrow Transplant. 2006 Mar;12(3):293-300. doi: 10.1016/j.bbmt.2005.10.019. Biol Blood Marrow Transplant. 2006. PMID: 16503498 Free article.

8

The impact of chimerism patterns and predonor leukocyte infusion lymphopenia on survival following T cell-depleted reduced intensity conditioned transplants.

Shaw BE, Byrne JL, Das-Gupta E, Carter GI, Russell NH. Shaw BE, et al. Among authors: russell nh. Biol Blood Marrow Transplant. 2007 May;13(5):550-9. doi: 10.1016/j.bbmt.2006.12.451. Epub 2007 Feb 15. Biol Blood Marrow Transplant. 2007. PMID: 17448914 Free article.

9

Long-term outcome of unrelated donor transplantation for AML using myeloablative conditioning incorporating pretransplant Alemtuzumab.

Das-Gupta EP, Russell NH, Shaw BE, Pearce RM, Byrne JL. Das-Gupta EP, et al. Among authors: russell nh. Biol Blood Marrow Transplant. 2007 Jun;13(6):724-33. doi: 10.1016/j.bbmt.2007.02.011. Biol Blood Marrow Transplant. 2007. PMID: 17531783 Free article. Clinical Trial.

10

Sequential influences of leukemia-specific and genetic factors on p-glycoprotein expression in blasts from 817 patients entered into the National Cancer Research Network acute myeloid leukemia 14 and 15 trials.

Seedhouse CH, Grundy M, White P, Li Y, Fisher J, Yakunina D, Moorman AV, Hoy T, Russell N, Burnett A, Pallis M; National Cancer Research Network. Seedhouse CH, et al. Clin Cancer Res. 2007 Dec 1;13(23):7059-66. doi: 10.1158/1078-0432.CCR-07-1484. Clin Cancer Res. 2007. PMID: 18056183

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

306 results

Search Page